GAPDH and renal cell carcinoma: Among the proteins, GAPDH exhibited the lowest binding energy, with an affinity of −9.1 kcal/mol, suggesting that GAPDH may be the most central target of esculin in the treatment of RCC (Figure 2A) (Supplementary Table S3).